Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Paleari

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The International Journal of Biological Markers|July 28, 2009
Osteopontin is not a specific marker in malignant pleural mesotheliomaLaura Paleari, Nicola Rotolo, Andrea Imperatori, et al.
The International Journal of Biological Markers|December 17, 2010
Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsyRoberto Puzone, Laura Paleari, Franco Montefiore, et al.
International Journal of Cancer|December 11, 2007
Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug developmentAlessia Grozio, Laura Paleari, Alessia Catassi, et al.
Journal of Leukocyte Biology|July 30, 2003
DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemiasNicoletta Ferrari, Giulio L Palmisano, Laura Paleari, et al.
Translational Oncology|April 5, 2020
Modulating the Distant Spreading of Patient-Derived Colorectal Cancer Cells via Aspirin and MetforminGemma Palazzolo, Hilaria Mollica, Valeria Lusi, et al.
Cancer Letters|April 13, 2011
A prognostic multigene classifier for squamous cell carcinomas of the larynxValentina Mirisola, Renzo Mora, Alessia Isabella Esposito, et al.
International Journal of Oncology|November 8, 2006
Marine sponge-derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumorsLaura Paleari, Sonya Trombino, Carla Falugi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2009
Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapyRolando M D'Angelillo, Lucio Trodella, Marzia Ciresa, et al.
Current Cancer Drug Targets|January 22, 2010
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferationRoberto E Favoni, Alessandra Pattarozzi, Michele Lo Casto, et al.
Current Medical Research and Opinion|November 2, 2021
Expert opinion and patients' in-depth interviews on the impact of pulmonary complications in systemic sclerosisAntonella Caminati, Barbara Vigone, Sergio Cozzaglio, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The International Journal of Biological Markers|July 28, 2009
Osteopontin is not a specific marker in malignant pleural mesotheliomaLaura Paleari, Nicola Rotolo, Andrea Imperatori, et al.
The International Journal of Biological Markers|December 17, 2010
Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsyRoberto Puzone, Laura Paleari, Franco Montefiore, et al.
International Journal of Cancer|December 11, 2007
Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug developmentAlessia Grozio, Laura Paleari, Alessia Catassi, et al.
Journal of Leukocyte Biology|July 30, 2003
DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemiasNicoletta Ferrari, Giulio L Palmisano, Laura Paleari, et al.
Translational Oncology|April 5, 2020
Modulating the Distant Spreading of Patient-Derived Colorectal Cancer Cells via Aspirin and MetforminGemma Palazzolo, Hilaria Mollica, Valeria Lusi, et al.
Cancer Letters|April 13, 2011
A prognostic multigene classifier for squamous cell carcinomas of the larynxValentina Mirisola, Renzo Mora, Alessia Isabella Esposito, et al.
International Journal of Oncology|November 8, 2006
Marine sponge-derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumorsLaura Paleari, Sonya Trombino, Carla Falugi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2009
Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapyRolando M D'Angelillo, Lucio Trodella, Marzia Ciresa, et al.
Current Cancer Drug Targets|January 22, 2010
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferationRoberto E Favoni, Alessandra Pattarozzi, Michele Lo Casto, et al.
Current Medical Research and Opinion|November 2, 2021
Expert opinion and patients' in-depth interviews on the impact of pulmonary complications in systemic sclerosisAntonella Caminati, Barbara Vigone, Sergio Cozzaglio, et al.
Pageof 5